23 related articles for article (PubMed ID: 30240636)
1. Obese donor mice splenocytes aggravated the pathogenesis of acute graft-versus-host disease via regulating differentiation of Tregs and CD4
Li Z; Gu J; Zhu Q; Liu J; Lu H; Lu Y; Wang X
Oncotarget; 2017 Sep; 8(43):74880-74896. PubMed ID: 29088831
[TBL] [Abstract][Full Text] [Related]
2. Good or bad cops: immune cells in aGVHD.
Stary G
Blood; 2023 Mar; 141(11):1238-1240. PubMed ID: 36929436
[No Abstract] [Full Text] [Related]
3. Tetramerization of pyruvate kinase M2 attenuates graft-versus-host disease by inhibition of Th1 and Th17 differentiation.
Wang M; Li QJ; Zhao HY; Zhang JL
Hum Cell; 2024 May; 37(3):633-647. PubMed ID: 38416276
[TBL] [Abstract][Full Text] [Related]
4. Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends.
Tuli HS; Rath P; Chauhan A; Ranjan A; Ramniwas S; Sak K; Aggarwal D; Kumar M; Dhama K; Lee EHC; Yap KC; Capinpin SM; Kumar AP
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671442
[TBL] [Abstract][Full Text] [Related]
5. Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation.
Moon J; Lee SY; Na HS; Lee AR; Cho KH; Choi JW; Park SH; Cho ML
Front Immunol; 2022; 13():922531. PubMed ID: 36059546
[TBL] [Abstract][Full Text] [Related]
6. FK506 and Lactobacillus acidophilus ameliorate acute graft-versus-host disease by modulating the T helper 17/regulatory T-cell balance.
Beak JA; Park MJ; Kim SY; Jhun J; Woo JS; Choi JW; Na HS; Lee SK; Choi JY; Cho ML
J Transl Med; 2022 Feb; 20(1):104. PubMed ID: 35216600
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cells therapy enhance immunoregulatory properties in acute graft versus host disease with combination of regulatory T cells.
Park MJ; Baek JA; Kim SY; Jung KA; Choi JW; Park SH; Kwok SK; Cho ML
J Transl Med; 2020 Dec; 18(1):483. PubMed ID: 33317573
[TBL] [Abstract][Full Text] [Related]
8. Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease.
Malard F; Gaugler B; Lamarthee B; Mohty M
Mucosal Immunol; 2016 Mar; 9(2):299-308. PubMed ID: 26813345
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin E ameliorates acute graft-versus-host disease by modulating Th17 cell subsets and inhibiting STAT3 activation.
Kim SY; Park MJ; Kwon JE; Jung KA; Jhun JY; Lee SY; Seo HB; Ryu JY; Beak JA; Choi JY; Cho ML
Immunol Lett; 2018 Nov; 203():62-69. PubMed ID: 30240636
[TBL] [Abstract][Full Text] [Related]
10. PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.
Lee SH; Moon SJ; Park MJ; Kim EK; Moon YM; Cho ML
Immunol Lett; 2014 Jul; 160(1):79-88. PubMed ID: 24718277
[TBL] [Abstract][Full Text] [Related]
11. GRIM19 ameliorates acute graft-versus-host disease (GVHD) by modulating Th17 and Treg cell balance through down-regulation of STAT3 and NF-AT activation.
Park MJ; Lee SH; Lee SH; Kim EK; Lee EJ; Moon YM; La Cho M
J Transl Med; 2016 Jul; 14(1):206. PubMed ID: 27391226
[TBL] [Abstract][Full Text] [Related]
12. Blocking activator protein 1 activity in donor cells reduces severity of acute graft-versus-host disease through reciprocal regulation of IL-17-producing T cells/regulatory T cells.
Park MJ; Moon SJ; Lee SH; Kim EK; Yang EJ; Min JK; Park SH; Kim HY; Yang CW; Cho ML
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1112-20. PubMed ID: 24813170
[TBL] [Abstract][Full Text] [Related]
13. Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs.
Park MJ; Lee SY; Moon SJ; Son HJ; Lee SH; Kim EK; Byun JK; Shin DY; Park SH; Yang CW; Cho ML
Transl Res; 2016 Jul; 173():115-130. PubMed ID: 27126953
[TBL] [Abstract][Full Text] [Related]
14. Role of HMGB1 in regulation of STAT3 expression in CD4(+) T cells from patients with aGVHD after allogeneic hematopoietic stem cell transplantation.
Xu YJ; Li L; Chen Y; Fu B; Wu DS; Li XL; Zhao XL; Chen FP
Clin Immunol; 2015 Dec; 161(2):278-83. PubMed ID: 26327693
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
